LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the FBR Capital Markets 12th Annual Spring Investor Conference on Wednesday, May 28, 2008 at 9:00 a.m. (ET) at The Grand Hyatt New York.
